shares from the existing shareholder (the “Share Acquisition Transaction”). Details of the Share Acquisition Transaction are as follows: 1. Subscription of 805,264 newly issued ordinary shares of Hero

Company upon the Share Sale and Purchase Agreement. 8. Benefits expected to be generated The Company considered the asset acquisition and expected to generate benefits to the Company and the Company’s

) 26.1 Share of Profit from Investments in Associates and Joint Ventures6 201.1 685.9 484.9 241.1 Income Tax (Expense) Income5 (17.1) (4.8) 12.3 (71.9) Profit attributable to Owners of the Parent 260.2

between Seller and the Company upon the Share Sale and Purchase Agreement. 8. Benefits expected to be generated The Company considered the asset acquisition and expected to generate benefits to the Company

370.6 404.0 33.4 9.0 Other Income4 32.0 22.2 (9.7) (30.5) Administrative Expenses (15.8) (28.8) (13.0) 82.6 Finance Costs (148.1) (104.3) 43.8 (29.6) Share of Profit from Investments in Associates and

into the sign of Share Sale and Purchase Agreement, including transfer of related brand names from the selling shareholder(s). According to the Notification of the Capital Market Supervisory Board No

) - หน้า 5 - 3) If GS can operate and generate earning per share as agreed during the period of agreement after Phase 2-4 start to operate water distribution. the Company would purchase more GS’s share in

110 per share, totaling of Baht 9.90 million from the shareholders of Trans.Ad (the “Sellers”) who are not the related persons of the Company (the “Transaction”). This Transaction is considered as an

) per share at a price of not more than PHP 18.181818 or equivalent to THB 12.65 per share with the total value not more than PHP 895,637,700 or equivalent to THB 623,095,147.89, based on the CCPH’s and

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager